Lotus Bio-Technology Development Corp. operating under the name Focal Point Healthcare, is an At-home, digital health testing corporation supporting women's health, men's health, dietary health and sexual health. The Company delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.

Employees

Sector

Healthcare Facilities & Services

More about the company

15/02/23	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
22/12/22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI

Market Cap	662K 581K 535K 499K 940K 62.96M 960K 6.44M 2.49M 30.9M 2.49M 2.43M 108M	P/E 2016	-58.1x	P/E 2017	-593x
Enterprise Value	731K 642K 591K 551K 1.04M 69.54M 1.06M 7.11M 2.75M 34.13M 2.75M 2.69M 119M	EV / Sales 2016	-	EV / Sales 2017	-
Free-Float	4.07%	Yield 2016 *	-	Yield 2017	-

15/02/23	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
22/12/22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI
13/12/22	Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding	CI
24/10/22	BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..	CI
16/08/22	Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director	CI
06/07/22	Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO	CI
05/07/22	Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.	CI
12/04/22	Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.	CI
07/04/21	Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017	CI
27/01/21	Lotus Bio-Technology Development Corp. Reports Earnings Results for the First Quarter Ended June 30, 2017	CI
10/04/19	Lotus Bio-Technology Development Corp. Announces Executive Changes	CI
21/12/18	Lotus Bio-Technology Development Corp. cancelled the acquisition of Coin Rig Solution.	CI
21/12/17	Lotus Bio-Technology Development Corp. entered into significant agreement with Coin Rig Solution.	CI

16/02/23	Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	AQ
25/10/22	Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	PR
30/08/22	Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	PR
19/08/22	Lotus Bio Technology Development : Current Report	PU
16/08/22	Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	PR

Director	Title	Age	Since
Michael Jay Solomon BRD	Director/Board Member	87	30/09/2022
William McDonald BRD	Director/Board Member	-	23/10/2022
William Graves BRD	Director/Board Member	-	-

Starflick.com Share Price OTC Bulletin Board

Stocks

US85529D2036

Healthcare Facilities & Services

Valuation: Starflick.com

Latest news : Starflick.com

Press Releases: Starflick.com

Managers and Directors: Starflick.com

Other Healthcare Facilities & Services

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	+1.31%	+2.89%	+50.63%	+51.61%	134B
HCA HEALTHCARE, INC.	+0.86%	+1.41%	+0.95%	+29.58%	87.24B
FRESENIUS SE & CO. KGAA	-0.21%	+1.94%	-3.29%	+57.75%	26.32B
QUEST DIAGNOSTICS INCORPORATED	+1.92%	+6.36%	+20.46%	+53.69%	23.91B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.51%	+0.47%	-21.03%	-26.44%	20.13B
TENET HEALTHCARE CORPORATION	+2.20%	+4.50%	+7.76%	+134.95%	16.47B
REDE D'OR SÃO LUIZ S.A.	+0.89%	+2.70%	-1.10%	+6.38%	14.78B
DAVITA INC.	+2.49%	+7.04%	+55.43%	+126.96%	14.64B
FRESENIUS MEDICAL CARE AG	-0.01%	-1.96%	-17.03%	-8.18%	12.26B
Average	+1.00%	+2.59%	+10.31%	+47.37%	38.83B
Weighted average by Cap.	+1.05%	+2.57%	+21.60%	+45.30%

	2016	2017
Net sales	-	-
Net income	-781K -686K -631K -588K -1.11M -74.26M -1.13M -7.59M -2.94M -36.45M -2.93M -2.87M -127M	-19.55K -17.16K -15.8K -14.72K -27.77K -1.86M -28.33K -190K -73.63K -912K -73.4K -71.82K -3.18M
Net Debt	-5 -4.39 -4.04 -3.77 -7.1 -475.36 -7.25 -48.6 -18.83 -233.34 -18.77 -18.37 -812.07	69.21K 60.76K 55.93K 52.12K 98.29K 6.58M 100K 673K 261K 3.23M 260K 254K 11.24M